23 May 2013
Keywords: COPD, Market forecasts, Decision Resources, LABA, LAMA, Boehringer Ingelheim, Olodaterol, Tiotropium
Article | 19 December 2011
As a result of an expanding aging population, increases in drug treatment and the uptake of premium priced combinations, the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.